Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson’s disease, or frailty compared to usual care: The PRE.C.I.S.A. Randomized Controlled Trial - La Porta, Fabio; Lullini, Giada; Caselli, Serena; Valzania, Franco; Mussi, Chiara; Tedeschi, Claudio; Pioli, Giulio; Bondavalli, Massimo; Bertolotti, Marco; Banchelli, Federico; D’Amico, Roberto; Vicini, Roberto; et al. (medRxiv, 2022)
Background Fall risk in the elderly is a major public health issue due to the injury-related consequences and the risk of associated long-term disability. However, the delivery of preventive interventions in usual clinical practice still represents a challenge.Aim To evaluate the efficacy of a multiple-component combined with a multifactorial personalized intervention in reducing fall rates in a mixed population of community-dwelling elderly, compared to usual care.Design Randomized Controlled Trial (NCT03592420, clinicaltrials.gov). Setting: Outpatients in two Italian centers.Population 403 community-dwelling elderly at moderate-to-high fall risk, including subjects with Parkinson’s Disease and stroke.Methods After the randomization, the described interventions were administered to the intervention group (n=203). The control group (n=200) received usual care and recommendations to minimize fall risk factors. Each participant received a fall diary and was followed by 12 monthly phone calls. The primary endpoint was the number of falls in each group over 12 months. The secondary endpoints were other fall-related indicators recorded at 12 months. Participants’ functioning was assessed at baseline (T1) and 3-month (T3).Results 690 falls were reported at 12 months, 48.8% in the intervention and 51.2% in the control group, with 1.66 (± 3.5) and 1.77 (± 3.2) mean falls per subject, respectively. Subjects with ≥ 1 fall were 236 (58.6%) and with ≥2 falls 148 (36.7%). No statistically significant differences were observed between groups regarding the number of falls, the falling probability, and the time to the first fall. According to the subgroup analysis, no significant differences were reported. A statistically significant difference was found for the Mini-BESTest (p=0.004) and the Fullerton Advanced Balance Scale (p=0.006) for the intervention group, with a small effect size (Cohen’s d 0.26 and 0.32, respectively), at T1 and T3 evaluations.Conclusions The intervention was ineffective in reducing the number of falls, the falling probability, and the time to the first fall at 12 months in a mixed population of community-dwelling elderly. A significant improvement for two balance indicators was recorded in the intervention group. Future studies are needed to explore different effects of the proposed interventions to reduce falls and consequences.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinicalTrials.gov ID: NCT03592420Funding StatementThis study was financed by the Agenzia Socio-Sanitaria Regionale della Regione Emilia-Romagna (Italy) in the context of the Programma di Ricerca Regione-Universita 2013 (PRUA2-2013-00002056)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local Ethical Committees (Provincial Ethics Committee of Modena 1141/CE/2014 and of Reggio Emilia 2014/0027233).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors